TickerFacts.

GeoVax Labs, Inc. (GOVX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2010-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$21.50M
Year ended 2025-12-31
-$18.37M
Trailing 12 months to 2026-06-30
2009-12-31: -$1.70M2010-12-31: -$2.44M2011-12-31: -$315.5K2013-12-31: -$1.78M2014-12-31: -$2.29M2015-12-31: -$2.72M2017-12-31: -$1.69M2019-12-31: -$1.41M2020-12-31: -$2.91M2021-12-31: -$11.24M2022-12-31: -$19.16M2023-12-31: -$25.22M2024-12-31: -$24.70M2025-12-31: -$21.50M-$21.50M
2009-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$21.50Mn/m2026-04-15, From 2025-01-01
2024-12-31-$24.70Mn/m2026-04-15, From 2024-01-01
2023-12-31-$25.22Mn/m2025-03-27, From 2023-01-01
2022-12-31-$19.16Mn/m2024-02-29, From 2022-01-01
2021-12-31-$11.24Mn/m2023-03-23, From 2021-01-01
2020-12-31-$2.91Mn/m2022-03-09, From 2020-01-01
2019-12-31-$1.41Mn/a2021-03-23, From 2019-01-01
No annual figure between 2017-12-31 and 2019-12-31.
2017-12-31-$1.69Mn/a2019-03-26, From 2017-01-01
No annual figure between 2015-12-31 and 2017-12-31.
2015-12-31-$2.72Mn/m2018-03-23, From 2015-01-01
2014-12-31-$2.29Mn/m2017-03-24, From 2014-01-01
2013-12-31-$1.78Mn/a2016-03-16, From 2013-01-01
No annual figure between 2011-12-31 and 2013-12-31.
2011-12-31-$315.5Kn/m2014-03-14, From 2011-01-01
2010-12-31-$2.44Mn/c2013-03-18, From 2010-01-01
2009-12-31-$1.70Mn/a2012-03-30, From 2009-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
GeoVax Labs, Inc. (GOVX)2025-12-31-$21.50Mn/m
Cartesian Therapeutics, Inc. (RNAC)2025-12-31-$79.39Mn/m
Upstream Bio, Inc. (UPB)2025-12-31-$133.44Mn/m
Lipocine Inc. (LPCN)2024-12-31-$1.31Mn/m
Camp4 Therapeutics Corp (CAMP)2025-12-31-$29.83Mn/m
Rani Therapeutics Holdings, Inc. (RANI)2025-12-31-$18.80Mn/m
China Pharma Holdings, Inc. (CPHI)2025-12-31$88.9Kn/m
NRX Pharmaceuticals, Inc. (NRXP)2024-12-31-$10.64Mn/m
ProPhase Labs, Inc. (PRPH)2025-12-31-$8.34Mn/m

Compare GOVX, RNAC, UPB, LPCN side by side · Screen every company in Pharmaceutical Preparations ↗